OWASP Gen AI Security Summit
In Partnership with Infosecurity Europe 2026
Securing Generative AI and Agentic Systems in the Era of Rapid AI Adoption
As Generative AI and autonomous agent systems move from experimentation to enterprise deployment, the security, governance and compliance landscape is evolving at unprecedented speed.
Join the OWASP GenAI Security Project for a half-day summit on Thursday 4th June at Infosecurity Europe 2026, where global project leaders, industry practitioners and regulatory experts will present the latest research, frameworks, and field-tested best practices for securing GenAI and agentic systems.
This exclusive summit will explore real-world risks, emerging threats, regulatory expectations, and proven approaches to building secure, compliant and resilient AI systems at scale.
Why Attend?
- Gain first access to the latest OWASP GenAI Security Project research
- Understand emerging security risks in agentic AI systems
- Learn how European regulatory developments are shaping AI security strategy
- Hear from organisations applying OWASP GenAI best practices in production
- Engage directly with project leaders and industry experts
Whether you’re a CISO, security architect, AI product leader, compliance executive or regulator, this summit will equip you with practical guidance and strategic clarity.
Why This Matters Now?
GenAI and agentic systems introduce fundamentally new security and governance challenges. Traditional application security approaches are not sufficient.
The OWASP GenAI Security Project, global expert community, has become a globally recognised authority in AI security best practices, with its work referenced by leading security and compliance groups across Europe and Globally.
This summit offers a unique opportunity to engage directly with the experts shaping the future of AI and agentic security.
The full agenda is coming soon.
Join us at Infosecurity Europe 2026 for a focused, high-impact half-day summit dedicated to securing the next generation of intelligent systems.